Skip to content
2000
Volume 6, Issue 3
  • ISSN: 1573-398X
  • E-ISSN: 1875-6387

Abstract

Noninvasive mechanical ventilation (NIV) is an effective treatment in acute hypercapnic respiratory failure associated with exacerbated chronic obstructive pulmonary disease and obesity hypoventilation syndrome, among other respiratory diseases. There is less scientific evidence on its application in situations of acute hypoxemic respiratory failure other than acute lung edema. There have been few randomized controlled trials on its efficacy versus standard oxygen therapy or conventional mechanical ventilation in the treatment of severe community-acquired pneumonia, and the results have been contradictory. Its application in selected immunosuppressed patients and patients with acute hypoxemic respiratory failure or chronic obstructive pulmonary disease-associated community-acquired pneumonia may reduce the orotracheal intubation rate, hospital stay, and mechanical ventilation-associated morbidity and mortality. A therapeutic trial with NIV may be appropriate in these situations, but only when the treatment can be continuously monitored and is controlled by specifically-trained professionals.

Loading

Article metrics loading...

/content/journals/crmr/10.2174/157339810791526210
2010-08-01
2025-10-19
Loading full text...

Full text loading...

/content/journals/crmr/10.2174/157339810791526210
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test